![](https://investorshub.advfn.com/uicon/108458.png?cb=1482855649)
Wednesday, September 06, 2023 2:54:28 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent INAB News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/12/2024 09:11:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:30:00 PM
- IN8bio Solidifies Position as a Clinical Leader of Gamma-Delta T Cell Therapy in Oncology with 100% of Treated AML Patients in Complete Remission and Receives FDA Guidance for Registrational Trial of INB-100 • GlobeNewswire Inc. • 08/12/2024 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:10:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:08:07 PM
- IN8bio Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
- IN8bio to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference • GlobeNewswire Inc. • 06/24/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 09:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 09:00:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 09:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 09:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:07:54 PM
- IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 • GlobeNewswire Inc. • 06/13/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 12:53:31 PM
- IN8bio Presents Progression-Free Survival Update from Phase 1 Study of INB-200 at 2024 American Society of Clinical Oncology Annual Meeting • GlobeNewswire Inc. • 06/03/2024 10:05:00 AM
- IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024 • GlobeNewswire Inc. • 05/24/2024 12:00:00 PM
- IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting • GlobeNewswire Inc. • 05/23/2024 09:00:00 PM
- IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress • GlobeNewswire Inc. • 05/14/2024 02:00:00 PM
- IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024 • GlobeNewswire Inc. • 05/13/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:06:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:04:17 PM
- IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 05/09/2024 08:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/07/2024 08:05:48 PM
- IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma • GlobeNewswire Inc. • 04/30/2024 10:05:00 AM
- IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting • GlobeNewswire Inc. • 04/24/2024 12:00:00 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM